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Abstract
Background: Metabolic stress associated with negative energy balance in high producing dairy cattle and obesity
in women is a risk factor for decreased fertility. Non-esterified fatty acids (NEFA) are involved in this pathogenesis as
they jeopardize oocyte and embryo development. Growing evidence indicates that maternal metabolic disorders
can disturb epigenetic programming, such as DNA methylation, in the offspring. Oocyte maturation and early
embryo development coincide with methylation changes and both are sensitive to adverse environments.
Therefore, we investigated whether elevated NEFA concentrations affect establishment and maintenance of DNA
methylation in oocytes and embryos, subsequently altering transcriptomic profiles and developmental competence
of resultant blastocysts.
Results: Bovine oocytes and embryos were exposed to different NEFA concentrations in separate experiments. In
the first experiment, oocytes were matured in vitro for 24 h in medium containing: 1) physiological (“BASAL”)
concentrations of oleic (OA), palmitic (PA) and stearic (SA) acid or 2) pathophysiological (“HIGH COMBI”)
concentrations of OA, PA and SA. In the second experiment, zygotes were cultivated in vitro for 6.5 days under
BASAL or HIGH COMBI conditions. Developmental competence was evaluated by assessing cleavage and blastocyst
rate. Overall gene expression and DNA methylation of resultant blastocysts were analyzed using microarray. DNA
methylation data were re-evaluated by pyrosequencing. HIGH COMBI-exposed oocytes and embryos displayed a
lower competence to develop into blastocysts compared to BASAL-exposed counterparts (19.3% compared to 23.
2% and 18.2% compared to 25.3%, respectively) (P < 0.05). HIGH COMBI-exposed oocytes and embryos resulted in
blastocysts with altered DNA methylation and transcriptomic fingerprints, compared to BASAL-exposed counterparts.
Differences in gene expression and methylation were more pronounced after exposure during culture compared to
maturation suggesting that zygotes are more susceptible to adverse environments. Main gene networks affected were
related to lipid and carbohydrate metabolism, cell death, immune response and metabolic disorders.
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Conclusions: Overall, high variation in methylation between blastocysts made it difficult to draw conclusions concerning
methylation of individual genes, although a clear overview of affected pathways was obtained. This may offer clues
regarding the high rate of embryonic loss and metabolic diseases during later life observed in offspring from mothers
displaying lipolytic disorders.
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Background
Non-esterified fatty acid (NEFA) concentrations are a
common feature of an impaired maternal metabolism,
typically observed in cows suffering negative energy bal-
ance but also in obese and type-II diabetes patients.
Earlier research has revealed that the fertility of females
suffering from these metabolic disorders is compromised
[1]. Awareness grows that NEFAs within the gamete’s
and/or embryonic microenvironment may play a key role
in causing this compromised fertility outcome [2]. Using a
bovine model, we and others have previously shown that el-
evated NEFA concentrations during oocyte maturation and
embryo culture are detrimental for embryonic development
[1, 3]. Additionally, elevated NEFA levels in the oocyte’s
microenvironment can affect gene expression, DNA methy-
lation at imprinted genes and alter the phenotype of result-
ant blastocysts [4–6]. Lower cell numbers and increased
apoptosis were observed in blastocysts after exposure
of oocytes to elevated NEFA concentrations. Moreover,
these blastocysts displayed reduced pyruvate, glucose
and oxygen consumption, increased lactate consumption
and altered amino acid metabolism compared to control
blastocysts [4]. Notably, oocyte maturation under high
NEFA concentrations significantly altered the expression
of genes involved in establishing methylation patterns
in the matured cumulus oocyte complex, as well as in
resultant day 7.5 blastocysts [5, 7]. Cumulus cells from
HIGH COMBI-exposed oocytes exhibited down-regulated
expression of DNMT3A [7], which is involved in de novo
methylation of cytosine residues at CpG sites in oocytes
and early preimplantation embryos until embryonic
genome activation [8, 9]. This finding also raises the
possibility of altered methylation status due to exposure
to adverse maternal metabolic conditions.
Genes regulating DNA methylation, e.g. DNMTs, are
crucial for driving appropriate growth and differentiation
in the developing embryo, especially during oocyte matur-
ation and early embryo development [9–12]. In the oocyte,
an increase in DNA methylation occurs during its growth
with the highest level reached at the germinal vesicle stage
[13, 14]. Following fertilization, DNA demethylation takes
place in the zygote and continues in the subsequent cleav-
age stages [15]. Re-establishment of general DNA methyla-
tion patterns succeeds embryonic genome activation [16].
At the time of blastocyst formation, DNA remethylation is
still an ongoing process that depends on blastocyst’s stage,
gender and ratio of inner cell mass (ICM) versus troph-
ectoderm (TE) [17]. During post-blastocyst development,
cell differentiation occurs with the establishment of cell
lineage-specific DNA methylation patterns [17, 18]. Taken
together, it is now generally accepted that oocyte matur-
ation and preimplantation embryo development are sensi-
tive windows for epigenetic reprogramming [19].
Biochemical changes in the oocytes microenvironment,
associated with maternal metabolic disturbances [20–22],
may result in alterations to the epigenome that, in turn, can
compromise fertility or even result in persistent changes
during fetal development or become visible after birth [23].
This concept is known as ‘Developmental Origins of adult
Health and Disease’ or DOHAD, first described by Barker
et al. [24]. In this context, Ge et al. [25] reported that
maternal diabetes mellitus can affect DNA methylation
imprinting in murine oocytes. Jungheim et al. [26] showed
that mouse embryos, exposed to elevated palmitic acid
concentrations, presented an altered embryonic metab-
olism and development, with lasting adverse effects on
growth patterns in offspring suggested to be associated
with aberrant epigenetic programming. Assisted reproduction
techniques have also been shown to influence epigenetic
mechanisms during oocyte maturation and preimplantation
embryo culture, leading to, for example, large offspring
syndrome in ruminants [27] or a higher risk for metabolic
syndrome in children born after in vitro fertilisation [28, 29].
We hypothesize that elevated NEFA concentrations
during oocyte maturation or embryo culture, the most
sensitive windows during which DNA methylation re-
programming occurs, jeopardize embryo developmental
competence by impacting the blastocysts transcriptome
and DNA methylation signatures. Considering the dy-
namic properties of DNA methylation at blastocyst stage
[17], we propose to focus first on overall affected path-
ways rather than on gene-specific changes. Therefore,
the aim of the present study was to examine the effect
of elevated NEFA concentrations during 24 h of oocyte
maturation or during 6.5 days of embryo culture on:
1. transcriptome signatures of resultant day 7.5
blastocysts and, in particular, the expression of genes
involved in epigenetic pathways using the bovine
EmbryoGENE microarray technique,
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2. whole-genome DNA methylation signatures of resultant
day 7.5 blastocysts using the EmbryoGENE DNA
Methylation Array (EDMA, http://emb-
bioinfo.fsaa.ulaval.ca/).
Methods
Experimental design
The types and concentrations of free fatty acids used in
this study are based on bovine in vivo studies in serum
and follicular fluid during a period of negative energy
balance [30] and have been reported for in vitro use be-
fore by Van Hoeck et al. [4]. Valckx et al. [22] also ob-
served that palmitic (PA, C16:0), stearic (SA, C18:0) and
oleic acid (OA, C18:1) are the most abundant NEFAs in
human follicular fluid of obese patients.
Two experiments were set up to characterize the devel-
opmental capacity and the transcriptomic and epigenomic
profile of the resultant day 7.5 blastocysts.
In the first (in vitro maturation or IVM) experiment,
the effect of elevated NEFA exposure during oocyte mat-
uration (24 h) on embryo development, gene expression
and DNA methylation profiles was evaluated by expos-
ing oocytes to the following conditions:
1. BASAL: physiological NEFA concentrations (72 μM
total NEFA containing 28 μM SA, 23 μM PA, and
21 μM OA).
2. HIGH COMBI: a combination of elevated NEFA
concentrations equivalent to those measured in the
follicular fluid during severe lipolytic conditions
(425 μM total NEFA, containing 75 μM SA, 150 μM
PA, and 200 μM OA).
In the second (in vitro culture or IVC) experiment, the
effect of elevated NEFA exposure during embryo culture
(6.5 days) on embryo development, gene expression pro-
file and DNA methylation was evaluated by exposing
embryos to the following conditions:
1. BASAL: physiological NEFA concentrations (72 μM
total NEFA containing 28 μM SA, 23 μM PA, and
21 μM OA).
2. HIGH COMBI: a combination of elevated NEFA
concentrations equivalent to those measured in serum
under high lipolytic conditions (720 μM total NEFA,
containing 280 μM SA, 230 μM PA, and 210 μM OA).
In order to evaluate the effects of elevated NEFA ex-
posure on embryo development, cleavage rate (48 h p.i.)
and blastocyst yield (7.5 days p.i.) were recorded in both
experiments. Evaluation of the gene expression profile of
blastocysts originating from NEFA-exposed oocytes was
previously performed by Van Hoeck et al. [5]. In the IVC
experiment, 4 replicates were produced to investigate
overall gene expression (using a total of 648 oocytes equally
distributed between treatments). Resultant day 7.5 blasto-
cysts were snap frozen for genome-wide analysis of tran-
scription (80 blastocysts, equally collected between
treatments in 4 replicates). Blastocysts from NEFA-exposed
oocytes (IVM experiment) and embryos (IVC experiment)
were produced for genome-wide analysis of DNA methyla-
tion profiles. A total of 1039 and 1412 oocytes were used
respectively, equally distributed between treatments in 4
replicates. Resultant day 7.5 blastocysts were snap frozen
for subsequent DNA methylation analysis (80 blastocysts
in each experiments, equally allocated between treat-
ments in 4 replicates). Results obtained from the EDMA
analysis were assessed using pyrosequencing of 4 inde-
pendent replicates of blastocysts in the IVM and IVC ex-
periment (879 and 809 oocytes respectively, equally
distributed between treatments). Pools of 10 blastocysts
were snap frozen per treatment and per replicate in both
experiments.
Preparation of NEFA treatments
Media containing NEFAs were prepared as previously
described by Van Hoeck et al. [4]. SA, PA and OA were
dissolved in a stock solution of pure ethanol at different
concentrations according to the experiment and treatment.
In the IVM experiment, NEFA stocks were prepared at
concentrations of 28, 23 and 21 mM for the BASAL treat-
ment and 25, 150 and 200 mM for the HIGH COMBI
treatment. In the IVC experiment, NEFA stocks were pre-
pared at concentrations of 28, 23 and 21 mM for the
BASAL treatment and 112, 230 and 210 mM for the HIGH
COMBI treatment, respectively. The final medium was
supplemented with fatty acid-free 0.75% bovine serum
albumin (BSA) in order to improve NEFA solubility.
In vitro embryo production
In vitro embryo production procedures were performed
as previously described by Van Hoeck et al. [4], using
immature oocytes retrieved from bovine ovaries collected
from a local abattoir within 2 h of slaughter. Briefly, grade
I cumulus oocyte complexes (COCs) were matured in
groups of 50–60 in 500 μl serum-free maturation medium
containing TCM199 supplemented with fatty acid-free
0.75% BSA, 0.4 mM glutamine, 0.2 mM sodium pyruvate,
0.1 mM cysteamine, 50 mg/ml gentamycin and murine
epidermal growth factor (mEGF, 20 ng/ml) for 24 h in hu-
midified air with 5% CO2 at 38.5 °C. In the IVM experi-
ment, oocytes were randomly divided in equal groups
between treatment-specific maturation media. In the IVC
experiment, oocytes were matured in serum-free matur-
ation medium as mentioned above. After IVM, COCs
were co-incubated in groups of 100–120 with spermato-
zoa at a final concentration of 106/ml for 22 h at 38.5 °C
in 500 μl fertilization medium (containing 114 mM NaCl,
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3.1 mM KCl, 0.3 mM Na2HPO4, 2.1 mM CaCl2-2H2O,
0.4 mM MgCl2-6H2O, 25 mM bicarbonate, 1 mM pyru-
vate, 36 mM lactate, 2 μL/ml phenol red, 6 mg/mL fatty
acid-free BSA, 50 μg/mL gentamycin and 0.72U/mL
heparin) in a humidified 5% CO2 incubator. Presump-
tive zygotes were cultured in groups of 25 ± 4. During
the IVM experiment, the presumptive zygotes were cul-
tured in 50 μl droplets of mSOF medium with a mineral
oil overlay (modular incubator: 38.5 °C, 5% CO2, 5% O2
and 90% N2) until the day of analysis. During the IVC
experiment, the presumptive zygotes were incubated in
a reduced surface 96-well dish containing 75 μl medium
without mineral oil overlay (modular incubator: 38.5 °C,
5% CO2, 5% O2 and 90% N2). The mSOF medium con-
tained 108 mM NaCl, 7.2 mM KCl, 1.2 mM KH2PO4,
0.8 mM MgSO4.7H2O, 0.6 mM sodium lactate, 25 mM
NaHCO3, 0.0266 mM phenol red, 0.73 mM sodium pyru-
vate, 1.78 mM CaCl2.2H2O, 0.34 mM trisodium citrate,
2.755 mM myoinositol, 3% v/v BME 50x, 1% v/v MEM
100x, 0.4 mM glutamine, 5% fetal bovine serum and
50 μg/mL gentamycin. For the IVC experiment, NEFAs
were added to the mSOF medium at concentrations ac-
cording to the treatment.
Transcriptomic analysis
Gene expression analysis using the bovine EmbryoGENE
microarray slides was performed as previously described
by Cagnone et al. [31]. Total RNA from pools of 10 blas-
tocysts (pools of normal and expanded blastocysts, equally
distributed per treatment and per replicate) was extracted
and purified using the PicoPure RNA Isolation Kit
(ThermoFisher Scientific, Ottawa, Ontario). After DNase
treatment (Qiagen, Toronto, Canada), quality and concen-
tration of the extracted RNA were analysed using a bioa-
nalyzer (Agilent, Diegem, Belgium). All extracted samples
showed good quality with an RNA integrity number >7.5.
In total, 42,242 total probes were covered including
21,139 known reference genes, 9,322 probes for novel
transcribed regions, 3,677 alternatively spliced exons,
3,353 39-tiling probes, and 3,723 control probes.
Quantification of DNA methylation patterns
DNA methylation analysis using the bovine Embryo-
GENE DNA Methylation Array (EDMA) was performed
as previously described by Shojaei et al. [32]. Genomic
DNA and total RNA were extracted from pools of 10
blastocysts (pools of normal and expanded blastocysts,
equally distributed per treatment and per replicate). The
microarray covered a total of 414,566 probes surveying
20,355 genes and 34,379 CpG islands. Data handling
was conducted using a built-in pipeline to perform pre-
processing (data quality control and normalization) and
analysis steps (statistical analysis and data sorting) [32]
(http://emb-bioinfo.fsaa.ulaval.ca/).
Targeted DNA methylation analysis using pyrosequencing
DNA was isolated from a pool of 10 blastocysts (pools
of normal and expanded blastocysts, equally distributed
per treatment and per replicate) and bisulfite converted
using the EZ methylation direct method (Zymo Research,
Freiburg, Germany) following the manufacturer’s guide-
lines. PCR reactions were carried out using the primers
summarized in Table 1. Each PCR reaction contained
16.75 μl H2O, 2.5 μl 10x Buffer, 0.5 μl dNTPS (10 mM),
0.5 μl forward and reverse primer (10 μM), 0.25 μl Plat-
inum Taq DNA polymerase, 1 μl MgCl2 (50 mM) and 3 μl
bisulfite DNA template (all products were purchased from
Invitrogen Life Technologies). Amplification was as fol-
lows: 95 °C for 5 min, then 40x 95 °C for 30 s, variable an-
nealing temperature (see Table 1) for 30 s, 72 °C for 30 s
and finally 72 °C for 30 s. Pyrosequencing was carried out
on a Pyromark Q24 instrument (Qiagen) as described by
Rutledge et al. [8]. Selection of the re-evaluated genes was
based on involvement in the most important pathways
(mentioned in the results) and that were also present in
the top 10 list of differentially methylated genes in IPA to
validate changes in DNA methylation of physiologically
relevant genes.
Statistical analyses
All statistical analyses of developmental competence
data were carried out with SPSS 22 (for Windows,
Chicago, IL, USA). Cleavage and blastocyst rates were
compared between the treatments (BASAL and HIGH
COMBI) using a binary logistic regression model. Rep-
licate (random factor), treatment (fixed factor) and their
interaction were taken into account. Differences were con-
sidered as being significant at P < 0.05 and as indicating a
trend at 0.05 < P < 0.1.
Relative transcript abundance generated through micro-
array was analysed with FlexArray; statistical data analysis
software for gene expression microarrays. Specifically, raw
data were corrected by background subtraction, and
then normalized within and between each array (Loess
and Quantile, respectively). Statistical comparison between
treatments was done with the Limma algorithm. A fold
change cut-off of 1.5 with P < 0.05 was set to identify genes
whose expression was significantly differentially regulated.
Data were analyzed by Ingenuity Pathways Analysis (IPA;
Ingenuity Systems, www.ingenuity.com) software, which
served to identify pathways that were differentially
expressed between treatments.
Bioinformatic analysis of the EDMA results was per-
formed as described by Shojaei et al. [32]. Briefly, the
Limma Bioconductor package was used to apply loess
intra-array normalization followed by Quantile inter-array
scale normalization to draw the intensities. Normalized in-
tensities were then fitted to a linear model and Bayesian
statistics of differential expression were obtained. Probes
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that exhibited a P-value < 0.05 and an absolute log2
fold-change of at least 1.5 were considered differentially
methylated regions (DMRs). Probes were categorized
based on their genomic locations, CpG islands-related
characteristics and the type of repeated elements covered.
Enrichment ratios were calculated by comparing the pro-
portion of probes in a given category across the whole
array to the same proportion within the DMRs. Data were
analyzed by Ingenuity Pathways Analysis (IPA; Ingenuity
Systems, www.ingenuity.com) software, which served to
identify pathways that were differentially methylated be-
tween treatments. For interpretation of individual differen-
tially methylated regions, a Benjamini-Hochberg correction
was applied to all P-values in order to correct for multiple
testing, thus reducing the chance of false positives.
Statistical analyses of the pyrosequencing results were
performed using the software package R, version 3.1.2. For
each gene, several CpG islands were tested in different
replicates, which created dependencies between the obser-
vations. To account for the dependence between observa-
tions within the same CpG island and the same replicate a
linear mixed model was fitted, where these dependencies
were taken into account by including random effect terms
into the model. The treatments (BASAL and HIGH
COMBI) were entered as fixed effects. The significance of
the fixed effect was tested using an F-test with a Kenward-
Roger correction for the degrees of freedom.
Results
Experiment 1. Blastocysts originating from NEFA-exposed
oocytes: consequences on gene expression and DNA
methylation signatures
Part 1A. Developmental competence of blastocysts
originating from NEFA-exposed oocytes
Cleavage rates of oocytes matured under HIGH COMBI
conditions (74.1%) were not significantly different
compared to BASAL conditions (72.3%) (P > 0.05). How-
ever, exposing oocytes to HIGH COMBI conditions re-
sulted in a significant reduction of the proportion of
oocytes reaching the blastocyst stage at day 7.5 p.i. (19.3%)
compared to BASAL-exposed oocytes (23.2%) (P < 0.05).
There was also a significantly lower capacity of cleaved
zygotes to develop to the blastocyst stage in the HIGH
COMBI group (26.0%) compared to the BASAL group
(32.1%) (P < 0.05). Data on developmental competence
are presented in Table 2.
Part 1B. Assessment of DNA methylation patterns using EDMA
Comparison of the methylome profile between blastocysts
originating from HIGH COMBI-exposed and BASAL-
exposed oocytes indicated that 395 loci were differentially
methylated (P < 0.05 and fold change >1.5). More specific-
ally, 240 loci were hypermethylated in the embryos origin-
ating from HIGH COMBI-exposed oocytes as compared
to embryos originating from BASAL-exposed oocytes;
whereas, DNA methylation at 155 loci was significantly
lower in the HIGH COMBI group as compared to the
BASAL counterparts as shown in Fig. 1.
Enrichment analysis of the data also identified which
specific genomic features (genomic localisation and
distance to CpG islands) were present in blastocysts
derived from HIGH COMBI-exposed oocytes and this
Table 1 Primers and annealing temperatures used for pyrosequencing
Forward primer Reverse primer Sequencing primer Annealing
temperature
COL6A3 AGGGAAGGTTGTTTAGAGGA ACCTAAAAATACTAATAACTAATCCATCA GGTTTTATATATAAGTAAAAGAA 57 °C
APAF1 TTTGGATGTTTTGTTAGATTGTAGTT AACTTACCACTACTACCCTCTAC ATTGGGTTTTGTGTG 54 °C
RFC4 TATTTTAAAGGAGATTAGTTTTGGGTGTT CTCAATTCAATCATAACTCAATCCTATA ATTGATGTTGAGGTTGAAA 60 °C
PLSCR3 TGGTTTTGTTGTTTGGTAGTTAAT CTCATATAACCAAACCCTTAATCTATC AGTTTTTTTATTTTAGTAGTTGG 54 °C
ELOVL1 GTTTTGTAGAGTTGGTGAGTGTA ATTTACTATCTAACCAAATCACTTCAC AGTTGGTGAGTGTATG 59 °C
TBKBP1 AGAGATGAGAAGGTTAGAGATTTAAGTAT AACCCTACCACATCTACATCCTCATA GTTTTAAATTAGTTGGGAGATA 58 °C
ERCC1 TTTTTAGTTTGGATATATAGATATGGGA ACTCAACCCCACTCATCT GGATATATAGATATGGGAAATATT 52 °C
CELF2 AGGAGAGAGGTGGTAATAATAAAGTTATA AACCAAAACCCTTTTCTCCA GTTGGTGATGAATTTGTAG 53 °C
ZFAND6 TGGGGAGGAGTATATGTGTATT CTTATTCTACCATTACTACTATTCTATCTT ATATGTGTATTTTTTTTTATTATAT 55 °C
PREX1 GGTTGGGTATTTATGTTTAGAAATTAAGT ACCTTCTCTATAATATTTATTCCTCTACC ATTAAGTGAGAAGGTATTTG 56 °C
APPL2 GTAGGTTTTATGGGGAAATTATGTAT TTCCATACCCTACCTATAAAAAATCTTC GTTTTTTTTTTTTATTGGGTAGA 55 °C
GCLC GTTAAATGGATGAGGGAGTTTAT ATTTTACTTCCACTATACCTAACTTT TGAATTATAGTTTTTTTTTAAAGTG 52 °C
Table 2 Developmental competence of bovine oocytes exposed
to elevated NEFA concentrations during 24 h of in vitro maturation
n (%) BASAL HIGH COMBI
Oocytes 990 928
Cleaved 716 (72.3) 688 (74.1)
Blastocysts from oocytes matured 230 (23.2)a 179 (19.3)b
Blastocysts from cleaved zygotes 230 (32.1)a 179 (26.0)b
Data indicated with different letters (ab) per row are significantly
different (P < 0.05)
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is presented in Fig. 2. The proximal promoter, pro-
moter and distal promoter regions were defined as the
first 1kbp, 5kbp and 50kbp of the transcription start
site. There appeared to be a tendency to conserve
DNA methylation within proximal promoters, exonic
regions and distal promoters. Conversely, differential
DNA methylation was more likely to occur at intronic
and intergenic regions and promoter sites. In addition,
analysis of the distance of probes relative to CpG
islands was performed. The probes were categorized
into CpG shores, CpG shelfs and open seas when they
were located 1-2 kbp, 2-4 kbp or >4 kbp away from the
nearest CpG island, respectively. Differentially methylated
regions were found in CpG shores, CpG shelfs and open
seas in the HIGH COMBI group. DNA Methylation at
CpG islands tended to be more stable and was not ob-
served to be affected by high concentrations of NEFAs
during oocyte maturation.
Among the loci that were differentially methylated
between embryos from HIGH COMBI-treated and
BASAL-treated oocytes, 148 hypermethylated and 120
hypomethylated regions mapped to coding-regions and
were used for further analysis using IPA. Output from
IPA analyses revealed that these coding-regions were
associated with cellular development and function, me-
tabolism, cell cycle, cell survival and death and gene ex-
pression (see Fig. 3). When applying a Benjamini-
Hochberg correction, no differentially methylated re-
gions displayed an adjusted P-value < 0.05 when com-
paring treatments.
The DNA methylation patterns were integrated with
the transcriptome data reported by Van Hoeck et al. [5]
to determine possible associations. In order to obtain a
general overview of pathways affected on transcriptome
and methylome level, microarray data without FDR cor-
rection were used for IPA analysis. In summary, transcrip-
tomic comparison between blastocysts originating from
oocytes matured under HIGH COMBI conditions com-
pared to BASAL conditions revealed that 190 genes
were differently expressed of which 85 up- and 105
down-regulated genes. These data were validated using
qRT-PCR. The correlation between specific differen-
tially methylated loci and expressed genes is presented
in Table 3.
Part 1C. Targeted analysis of DNA methylation
Methylation profiles of specific genes of interest were eval-
uated using pyrosequencing techniques in embryos from
HIGH COMBI-treated and BASAL-treated oocytes. The
selected genes (COL6A3, APAF1, RFC4, PLSCR3, ELOVL1
and TBKBP1) are associated with pathways such as apop-
tosis, metabolism, gene transcription and inflammatory
response. In addition, DNA methylation at two imprinted
genes, H19 and SNRPN, was also determined in embryos
Fig. 1 Volcano plot of the DNA methylation microarray results in blastocysts originating from HIGH COMBI-exposed oocytes versus blastocysts
originating from BASAL-exposed oocytes. The dots located at the left upper corner are significantly hypomethylated probes (n = 155); whereas,
the dots located at the right upper corner are significantly hypermethylated probes (n = 240) at P < 0.05 and fold change >1.5
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derived from HGH COMBI- and BASAL-treated oocytes.
The degree of DNA methylation of these imprinted genes
is known and therefore, they were implemented as con-
trols (see Fig. 4).
Methylation at the two imprinted genes (SNRPN and
H19) was not significantly different between embryos
from BASAL- and HIGH COMBI-exposed oocytes (28.0%
compared to 29.0% for SNRPN and 24.8% compared to
29.9% for H19). Only APAF1 (P = 0.40) and, to a lesser
extent, RFC4 (P = 0.20) showed hypermethylation (not
statistically significant) in embryos from HIGH COMBI-
treated as compared to embryos from BASAL-treated
Fig. 2 Enrichment of differentially methylated regions (DMRs) according to genic regions (left) and distance from CpG island (right) (with a CpG
shore, CpG shelve and open sea located 1–2 kbp, 2–4 kbp and >4 kbp away from the nearest CpG island, respectively) in blastocysts originating
from HIGH COMBI- exposed oocytes. Enrichment is defined as log2 (proportion of DMR probes within category / proportion of total probes in
that category). A bar of length 1 indicates that there are twice as many differentially methylated probes in that category as expected. The
numbers besides a bar represent how many DMRs fit in that category and the percentage of all DMRs in that category
Fig. 3 Results of biofunction analysis with the Ingenuity software for a DNA methylation microarray. The top 10 pathways affected in blastocysts
originating from HIGH COMBI-exposed oocytes versus blastocysts originating from BASAL-exposed oocytes are arranged by descending P-value
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oocytes as was observed in the microarray results, while
none of the hypomethylated genes (based on the micro-
array results) could be validated using pyrosequencing.
Experiment 2. Blastocysts originating from NEFA-exposed
embryos: consequences on gene expression and DNA
methylation signatures
Part 2A. Developmental competence of blastocysts originating
from NEFA-exposed embryos
Cleavage rates of embryos cultured under HIGH COMBI
conditions (65.2%) were significantly different compared
to BASAL conditions (75.6%) (P < 0.05). Moreover, expos-
ing embryos to HIGH COMBI conditions resulted in a
significant reduction of the proportion of embryos reach-
ing the blastocyst stage at day 7.5 p.i. (18.2%) compared to
BASAL-exposed oocytes (25.3%) (P < 0.05). There was also
a significantly lower capacity of cleaved zygotes to develop
to the blastocyst stage in the HIGH COMBI group
(27.9%) compared to the BASAL group (33.5%) (P < 0.05).
Data on developmental competence are presented in
Table 4.
Part 2B. Consequences for expression patterns of genes
involved in epigenetic pathways using microarray approach
The microarray platform identified 311 differentially
expressed genes (P < 0.05 and fold change > 1.5) between
blastocysts originating from embryos cultured under HIGH
COMBI and BASAL conditions. More specifically, 206
genes were up-regulated; whereas, 105 genes were down-
regulated (see Fig. 5). To validate the results of the micro-
array with an independent analysis, we used qRT-PCR
(as described by Van Hoeck et al. [5]) to examine a
Table 3 Relation between differentially methylated genes and downstream expressed genes of blastocysts originating from oocytes
exposed to high NEFA concentrations
Associated pathways Differentially methylated genes Downstream differentially expressed genes
Apoptosis TP53 SIRT1, MAD2L1, FAM3C, CDC7, CD47, HERC5, HSPD1,SCP2, UBL3, ID3
Embryo implantation LIF GPCPD1, CYP11A1
Gene transcription CTBP1 SIRT 1
IGF1R PDCD10, SCP2, KRT19, CYP11A1
Immune response TCR HERC5, HSPD1, GBP4, ID3
RXRB CCL17
Metabolism G6PC CYP11A1
LEP SC4MOL, SCP2, TIMP1
PEPCK CYP11A1
Fig. 4 Methylation patterns of H19, SNRPN, COL6A3, APAF1, RFC4, PLSCR3, ELOVL1 and TBKBP1 in blastocysts originating from HIGH COMBI-exposed
oocytes versus blastocysts originating from BASAL-exposed oocytes. Bars are presented as means ± SEM
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subset of 5 genes from the differentially regulated gene
list. The pattern of 4 of the transcripts mirrored that seen
on the arrays in terms of the direction of the change
(up- or down-regulated).
IPA analysis indicated that the following networks were
affected by the HIGH COMBI treatment during embryo
culture; cell morphology, cell-to-cell signaling and inter-
action, hematological system development and function,
lipid metabolism, small molecule biochemistry, vitamin
and mineral metabolism, lipid metabolism and molecular
transport (see Fig. 6).
Based on the transcriptomic patterns of blastocysts
originating from HIGH COMBI-treated embryos relative
to blastocysts originating from BASAL-treated embryos,
changes in only a single gene associated with epigenetic
modifications was identified, SHMT1. SHMT1 was down-
regulated in blastocysts that were cultured under HIGH
COMBI conditions (P < 0.001 and fold change = −1.892).
Part 2C. Assessment of DNA methylation patterns using EDMA
Comparison of the methylome profile between blasto-
cysts, originating from embryos cultured under HIGH
COMBI and those cultured under BASAL conditions,
indicated that 4,671 loci were differentially methylated
(P < 0.05 and fold change >1.5). Results are summarised
in Fig. 7. More specifically, 1,912 loci were hypermethy-
lated in HIGH COMBI as compared to BASAL embryos;
whereas, DNA methylation of 2,759 loci was significantly
lower in HIGH COMBI as compared to BASAL treated
embryos.
Enrichment analysis of the data also determined which
genomic features were present following exposure of the
developing embryo for HIGH COMBI conditions and
this is presented in Fig. 8. There was again a tendency to
changes in methylation at intronic or intergenic regions.
The level of methylation at promoter sites and exonic re-
gions was not affected by the HIGH COMBI treatment.
The distance of DMRs to CpG islands was determined as
described above. DMRs were found in CpG shores, CpG
Table 4 Developmental competence of bovine embryos
exposed to elevated NEFA concentrations during 6.5 days of in
vitro culture
n (%) BASAL HIGH COMBI
Oocytes 1217 1199
Cleaved 920 (75.6)a 782 (65.2)b
Blastocysts from oocytes matured 308 (25.3)a 218 (18.2)b
Blastocysts from cleaved zygotes 308 (33.5)a 218 (27.9)b
Data indicated with different letters (ab) per row are significantly
different (P < 0.05)
Fig. 5 Volcano plot of the microarray results in blastocysts originating from HIGH COMBI-exposed embryos versus blastocysts originating from
BASAL-exposed embryos. The dots which are located in the left upper corner of the plot are the significantly down-regulated genes; whereas, the
dots located in the right upper corner of the plot are those which are significantly up-regulated (P < 0.05 and fold change >1.5)
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shelves and open seas. Methylation at CpG islands tended
to be conserved.
Of the loci that were differentially methylated between
HIGH COMBI and BASAL embryos, 1576 mapped to
coding-regions and were used for subsequent pathway
analysis. Of these, 697 were hypermethylated and 879
were hypomethylated. Using these genes as input for IPA
it was determined that the main molecular and cellular
functions altered were overall related to cellular develop-
ment and function, metabolism, cell cycle, cell death and
survival and gene expression (see Fig. 9). When applying a
Benjamini-Hochberg correction, no differentially methyl-
ated regions had an adjusted P-value < 0.05 when compar-
ing treatments.
Fig. 6 Results of biofunction analysis with the Ingenuity software for microarray. The top 10 pathways affected in blastocysts originating from
HIGH COMBI-exposed embryos versus blastocysts originating from BASAL-exposed embryos are arranged by descending P-value
Fig. 7 Volcano plot of the microarray results in blastocysts originating from HIGH COMBI-exposed embryos versus blastocysts originating from
BASAL-exposed embryos. The dots located in the left upper corner are statistically significantly hypomethylated probes (n = 879); whereas, the
dots located in the right upper corner are statistically significantly hypermethylated probes (n = 697) (P < 0.05 and fold change >1.5)
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The DNA methylation data were compared with
transcriptome profiles to investigate a possible associ-
ation between changes in DNA methylation and gene
expression. In order to maximize visualization of simi-
lar affected pathways, microarray data before FDR
correction were applied for IPA analysis. The latter infor-
mation is not used to draw conclusions at individual
gene level. The correlation between specific differen-
tially methylated loci and expressed genes is presented
in Table 5.
Fig. 8 Enrichment of differentially methylated regions (DMRs) according to genic regions (left) and distance from CpG island (right) (with a CpG
shore, CpG shelve and open sea located 1–2 kbp, 2–4 kbp and >4 kbp away from the nearest CpG island, respectively) in blastocysts originating
from HIGH COMBI-exposed embryos. Enrichment is defined as log2 (proportion of DMR probes within category / proportion of total probes in
that category). A bar of length 1 indicates that there are twice as many differentially methylated probes in that category as expected. The
numbers besides a bar represent how many DMRs fit in that category and the percentage of all DMRs in that category
Fig. 9 Results of biofunction analysis with the Ingenuity software for a DNA methylation microarray. The top 10 pathways affected in blastocysts
originating from HIGH COMBI-exposed embryos versus blastocysts originating from BASAL-exposed embryos are arranged by descending P-value
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Part 2D. Targeted analysis of DNA methylation
In order to re-evaluate the DNA methylation microarray
results, we investigated the methylation profiles of
ERCC1, CELF2, ZFAND6, PREX1, APPL2 and GCLC in
HIGH COMBI and BASAL embryos using pyrosequenc-
ing. The average methylation level at two imprinted gene
DMRs, H19 and SNRPN, was also determined in both
BASAL and HIGH COMBI embryos as controls. The
average methylation level of the selected genes of HIGH
COMBI- compared to BASAL-treated embryos is pre-
sented in Fig. 10.
SNRPN had an average methylation level of 28.1% in
BASAL embryos compared to 31.5% in HIGH COMBI
embryos. For the H19 DMR, similar methylation levels
were observed in BASAL (22.8%) and HIGH COMBI
(25.8%) embryos. ERCC1 (P = 0.16), CELF2 (P = 0.52)
and ZFAND6 (P = 0.81) showed hypermethylation in
HIGH COMBI embryos compared to control embryos as
was observed in the microarray results (not statistically
significant). Hypomethylation of HIGH COMBI embryos
compared to BASAL embryos was also observed for
APPL2 (P = 0.45) (not statistically significant).
Discussion
It has been shown previously that elevated NEFA con-
centrations, as present in several metabolic disorders,
can impair oocyte and embryo developmental competence
and influence transcriptomic and phenotypic fingerprints
of resultant blastocysts [5, 7]. Here, we provide evidence
that alterations to the epigenome occur in response to
conditions of elevated NEFA concentrations during oocyte
maturation or early embryo culture. Major affected path-
ways are related to cell death and survival, immunity, me-
tabolism and metabolic disorders. Although interpretation
of methylation rates at individual loci remained difficult as
high rates of variation were observed in methylation
patterns between blastocysts within treatment groups,
the data shed a clear light on the heatmap of pathways
affected by an adverse environment. These epigenetic
changes may contribute to the observed transcriptomic
and phenotypic alterations and could persist during fur-
ther development.
Following exposure of oocytes to pathophysiological
concentrations of NEFAs, the main pathways affected at
the transcriptomic level in blastocysts were related to
lipid and carbohydrate metabolism, small molecule bio-
chemistry and cellular development as described by Van
Hoeck et al. [5]. Furthermore, transcriptomic data-
analysis revealed that NEFA exposure during oocyte
maturation affected the expression of genes related to
epigenetic programming; HIST1H2BN, UBA2 and PPP1CB.
For example, HIST1H2BN encodes a histone that is a
member of the histone H2B family and functions in
the compaction of chromatin and thus in histone
Table 5 Relation between differentially methylated genes and downstream expressed genes of blastocysts originating from
embryos exposed to high NEFA concentrations
Associated pathways Differentially methylated genes Downstream differentially expressed genes
Apoptosis TP53 SERPINE1, DCTN2, CNN3, BHLHB2, MTDH, ASNS, GLB1, CNN1, HMGCS1,
CCND2, LBR, ANKH, NANOG, SEC61B, HSPG2, COX7A2, GZMB, IGFBP7
Autophagy ATG16L1 UPK1A
Cell cycle TERF2 GLB1
Cell differentiation FGFR2 CCND2, NANOG, NR5A2
Cell interaction Alpha catenin RHOC, IGFBP7, TWIST2
Cell signaling ERK1/2 SERPINE1, CCND2, LDLR, NANOG, RHOC
ITGAV SERPINE1, LDLR
Cell survival FGF10 SCD, LDLR, LFNG
Cellular development THPO CCND2, GP1BA
Hormonal regulation estrogen receptor SERPINE1, CCND2, LDLR, MUC1
FSH SERPINE1, CCND2, LDLR, AQP3, ARL4C, GZMB, CARD10, DUSP14, GATA4
FSHR GATA4, GZMBΔ
Immune response CD28 TOM1L1, CCND2, TXNRD1, PA2G4, AQP3, SEC61B, RHOC, GZMB, DUSP14
Cg BHLHB2, CCND2, LDLR, S100A10, NR5A2, GATA4
TCR LBR, PA2G4, GZMB, ARPP21, LMNB1
Ion transport WNK1 SERPINE1
Gene transcription Creb MIF, HSPB8, LDLR, ELL
PRDM16 SERPINE1
SMARCA4 SERPINE1, MUC1, ASNS, FLNB, TXNRD1, ARL4C
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modifications [33]. Such histone modifications in fetal
primates have been previously linked to conditions of
maternal overnutrition [34]. Therefore, we assumed
that high NEFA concentrations, associated with mater-
nal metabolic disorders, also impact on epigenetic
mechanisms.
Genome-wide analysis revealed that elevated NEFAs
during oocyte maturation influenced overall DNA methy-
lation patterns in the resultant blastocysts, affecting many
DMRs associated with cell death and survival and cellular
metabolism. Aberrant DNA methylation patterns were
observed in pathways related to caspase activation, p53-
induced apoptosis, Ras-signalling and Wnt-signalling. The
latter observations are in line with the phenotypic data
published by Van Hoeck et al. [4], reporting an increased
apoptotic cell ratio in blastocysts from HIGH COMBI- as
compared to BASAL-exposed oocytes. Previously, Ge
et al. [35] demonstrated an association between maternal
metabolic disorders and epigenetic regulation of oocyte
metabolism in mice. Similarly, our data revealed methyla-
tion changes in lipid transfer and synthesis pathways in
blastocysts originating from HIGH COMBI-exposed oo-
cytes. Similar transcriptome and phenotypic fingerprints
of blastocysts originating from HIGH COMBI-exposed
oocytes were previously described [5, 7]. Epigenetic
alterations were also observed in pathological processes
such as obesity and insulin-dependent diabetes. These
alterations in insulin signalling are interesting since an
excessive uptake and accumulation of fatty acids in
somatic cell lines is known to be closely associated with
type II-diabetes [36], as for example shown in muscle
cells by Bilan et al. [37]. Furthermore, Van Hoeck et al.
[4, 5] observed phenotypic features associated with glu-
cose intolerance in blastocysts originating from HIGH
COMBI-exposed oocytes.
Following exposure of developing embryos to elevated
NEFA concentrations during culture, the main pathways
affected in resultant blastocysts using transcriptomic ana-
lysis were similar to those in the IVM experiment, i.e. lipid
and carbohydrate metabolism, small molecule biochemis-
try and cellular development. Down-regulation of genes
related to embryonic cell growth, cell differentiation and
cell-cell interaction suggests a reduced developmental
competence of blastocysts from HIGH COMBI-treated
embryos. Interestingly, HIGH COMBI exposure during
embryo culture also affected the expression of a gene
required for DNA synthesis and methylation, SHMT1.
Down-regulation of SHMT1 has previously been shown
to increase methionine formation and thus might affect
DNA methylation [38]. Overall changes in DNA methy-
lation were indeed observed in blastocysts from HIGH
COMBI-exposed embryos.
DNA methylation analysis of blastocysts originating
from HIGH COMBI-exposed embryos revealed altered
Fig. 10 Methylation patterns of ERCC1, CELF2, ZFAND6, PREX1, APPL2 and GCLC in blastocysts originating from HIGH COMBI-exposed embryos
versus blastocysts originating from BASAL-exposed embryos. Bars are presented as means ± SEM
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methylation at loci of genes related to pathways associ-
ated with apoptosis, such as the Ras/MAPK signalling
[39], the formation of antioxidants [40] and mitochondrial
dysfunction [41]. ‘Molecular transport’ pathways, for
example involved in regulation of endosomal cholesterol
trafficking by recycling sterol carrier proteins, were sig-
nificantly affected [42]. Overall lipid metabolism was af-
fected by high NEFA exposure with particular focus on
pathways as adipogenesis, adipocyte differentiation and
fatty acid synthesis [43]. Exposure of embryos to high
NEFA concentrations not only influenced lipid but also
glucose metabolism, as for example observed in glucose
transport [44–46]. Some metabolism- or immune
response-related genes are also associated with obesity
and insulin resistance [41, 47–50]. Alterations in these
pathways may further affect the offspring since mater-
nal metabolic disorders have been shown to increase
the risk of developing metabolic disorders in the off-
spring [51].
Even though the aim of the present study was to achieve
a broad overview of affected pathways, an attempt was
made to verify DNA methylation at gene level in both
IVM and IVC experiments by three different approaches.
Validation of EDMA array data using other techniques
has been proven difficult due to the non-linear amplifi-
cation steps involved in array generation. Shojaei et al.
[32] have shown that pyrosequencing offers a partial so-
lution to this problem, whereby methylation trends (gain
or loss) generally replicate. Therefore, we chose this
technique in the first approach to validate the array. Only
two and four of the six genes showed a similar trend in
methylation direction as observed with the microarray in
the IVM and IVC experiment, respectively. None of these
differences were statistically significant due to the high
variability and thus pyrosequencing could not confirm the
microarray results. In this context, such a high level of
variation in average methylation between replicates in
bovine day 7 blastocysts has also been observed by
O’Doherty and McGettigan [12]. The latter authors
suggested that the observed variability in DNA methy-
lation at day 7 may be due to preferential amplification
of maternal or paternal alleles, overrepresentation of DNA
from the ICM or the TE or differences between gender.
This variation in DNA methylation between blastocysts
was previously described by Dobbs et al. [17].
In the second approach, gene-specific methylation was
assessed by applying an FDR correction to the micro-
array data. The digestion protocol targets specific cyto-
sines that are not necessarily alone in the methylation
landscape creating a bias towards the analysis of these
sites compared to all sites [32]. In the context of rela-
tively small individual changes for any specific DMR, the
power obtained is not sufficient to create a list of defined
targets. Therefore, a Benjamini-Hochberg correction was
applied to the list of DMRs to adjust for the number of
targets. No DMRs remained when the stringency was
raised to the maximum, indicating that the differences
due to the NEFA treatment were minimal at gene level.
Additionally, this test is highly sensitive to the number
of biological replicates [52] and the present study used,
due to practical limitations, four biological replicates.
Bioinformatic tools, such as IPA, are consequently required
to identify if the distribution of the hundreds of DMRs is
random or associated with specific functions of pathways.
Analysis of the DMR lists with the IPA software unraveled
significant changes in multiple pathways due to NEFA
exposure as explained above.
In the last approach, methylome data were compared
with transcriptome data to examine if genes displayed
changes in both DNA methylation and gene expression
signatures. It is generally accepted that methylation is im-
plied in expressing/silencing of the gene [53]. However, no
differentially methylated loci did result in modified gene
expression patterns. This discrepancy between methylation
and expression was also observed by Salilew-Wondim
et al. [54] who suggested that changes in DNA methylation
could not only result in modifications of mRNA expression
but also alter the expression of other non-coding RNAs.
Moreover, epigenetic regulation of gene expression is com-
plex and also involves additional epigenetic mechanisms
like histone modifications [33]. Besides the discrepancy of
transcriptome and methylome changes of individual genes,
comparable changes were observed at the level of path-
ways. In this context, IPA analysis confirmed an overlap
between pathways displaying altered gene expression and
DNA methylation and thus suggests that DNA methylation
is an epigenetic trigger for changes in gene expression due
to elevated NEFA exposure.
Based on the lack of validation using these different
approaches, we conclude that in the present study the
EDMA array was not able to detect changes in DNA
methylation in order to draw specific conclusions at the
level of an individual gene. Aside from the methodological
restrictions, the blastocyst as such is a difficult target for
methylation analysis. Rekik et al. [55] observed very dy-
namic gene expression profiles during a relatively short
time period encompassing blastocyst formation and hatch-
ing. Similarly, changes in DNA methylation fingerprints
emerge from fertilization onwards. DNA methylation de-
clines as the embryo undergoes successive cell divisions to
a nadir at the 6–8 cell stage and increases thereafter. At
blastocyst level, DNA methylation varies depending upon
gender and cell lineage as demonstrated by Dobbs et al.
[17]. Even imprinted genes, which are resistant to epigen-
etic reprogramming, may be susceptible to instability at
the blastocyst stage [56]. We tried to minimize these effects
by pooling embryos of similar stages across treatments and
replicates to generate comparable biological replicates
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although the extent of DNA methylation still remains
naturally variable among samples of similar origin. Not-
withstanding these limitations, the blastocyst is an in-
teresting target to investigate. Transcriptome studies have
extensively shown how early embryos interact with their
immediate microenvironment [31, 57, 58]. Epigenetic re-
programming at this stage puts the embryo at risk of
programming errors with potential long-term conse-
quences due to an adverse environment [23].
Comparison of data from NEFA exposure during IVM
(24 h) and IVC (168 h) demonstrated that a higher num-
ber of differentially expressed genes and aberrantly
methylated loci were present in response to elevated
NEFA concentrations during IVC compared to IVM. All
data regarding changes in DNA methylation, gene ex-
pression profile and associated affected canonical path-
ways in the IVM and IVC experiment are summarized
in Fig. 11. Indeed, it is likely that oocytes are less sensi-
tive to NEFA exposure than embryos due to the presence
of the surrounding cumulus cells. It has been observed
that the cumulus cells incorporate fatty acids as lipids and
thereby protect the oocyte from in vitro induced lipotoxic
effects [59, 60]. Moreover, oocytes rely on oxidative fatty
acid metabolism during final maturation [61]. Embryos,
however, use pyruvate and glucose as energy sources [62].
This change in energy source during development could
contribute to the smaller effect of NEFA exposure ob-
served during oocyte maturation as compared to embryo
culture. The window of exposure may also determine the
extent of DNA methylation dysregulation and regulation
of gene expression. DNA methylation increases during
oocyte growth and these marks are erased shortly after
fertilization, which could provide an opportunity to com-
pensate for aberrant DNA methylation incurred during
IVM. This could account for the lower number of differ-
entially methylated loci noticed in blastocysts derived
from NEFA-exposed oocytes, compared to blastocysts de-
rived from NEFA-exposed embryos. Salilew-Wondim
et al. [54] recently suggested a similar hypothesis as they
observed a strong positive association between the extent
Fig. 11 Main canonical pathways showing significant differences in DNA methylation (upper panel) and gene expression (lower panel) in the IVM
(left table) and the IVC (right table) experiment. Number of genes showing hyper- (red) and hypo- (green) methylation (upper panel) or up- (red)
and down- (green) regulation (lower panel) in blastocysts originating from HIGH COMBI-exposed oocytes versus blastocysts originating from
BASAL-exposed oocytes (IVM) and in blastocysts originating from HIGH COMBI-exposed embryos versus blastocysts originating from BASAL-exposed
embryos (IVC)
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of DNA methylation dysregulation and the developmental
stages completed under in vitro conditions.
Finally, the current study not only helps to unravel the
window of epigenetic sensitivity for environmental changes
in NEFA concentrations, but also should be integrated to
see potential associations between DNA methylation, gene
expression and phenotypic profiles. The correlation be-
tween canonical pathways in which genes were differ-
entially methylated and expressed was investigated in
both IVM and IVC experiments and has been presented
in Fig. 11. Overall, pathways affected in both IVM and
IVC experiments were mostly related to apoptosis, amino
acid metabolism, lipid metabolism and carbohydrate
metabolism.
Conclusions
In the present study, we were only able to acquire an
overall perspective of the extent of the differences in
methylation. A more in-depth assessment of DNA methy-
lation changes at the level of individual genes was not
feasible due to both methodological and biological limita-
tions. Although the EDMA array provides a robust whole-
genome view of DNA methylation in bovine early embryos,
subtle alterations are not detected through multiple testing
corrections. Additionally, vast epigenetic erasure and repro-
gramming events during early embryogenesis make this
phase of development a sensitive window for perturbations.
This dynamic window makes the blastocyst both an intri-
guing and complicated target for further research.
Elevated NEFA concentrations during either in vitro
oocyte maturation or embryo development as observed
in females suffering metabolic disorders associated with
upregulated lipolysis, impact the resultant blastocysts’
transcriptomic and epigenetic profiles. Key cellular
pathways affected by NEFA exposure are similar after
integration of gene expression and methylation patterns,
with particular reference to lipid and carbohydrate metab-
olism, cell death, immune response and metabolic disor-
ders. Furthermore, early cleavage embryos were even more
susceptible to altered in vitro conditions than oocytes dur-
ing maturation, as a higher level of epigenetic dysregulation
was evident in the former. This information is crucial for
helping to elucidate the underlying mechanisms of sub-
fertility and development of metabolic disease in the
offspring. It suggests that maternal metabolic disorders
can influence epigenetic reprogramming in the embryo
and affect subsequent development, potentially imprinting
long-lasting marks during later stages of adult life. How-
ever, more research is necessary to investigate long-term
effects of this epigenetic dysregulation.
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